Interleukin-6 Mediates G0/G1 Growth Arrest in Hepatocellular Carcinoma Through a STAT 3-Dependent Pathway
Authors:
- Paul A. CahillPCPaul A. Cahill
- Leonidas G. KoniarisLKLeonidas G. Koniaris
- Iain H. McKillopIMIain H. McKillop
- 1 June 2008
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 147 (1) , 23-33
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinomaLiver International, 2005
- Jak2 Tyrosine Kinase Mediates Angiotensin II-dependent Inactivation of ERK2 via Induction of Mitogen-activated Protein Kinase Phosphatase 1Journal of Biological Chemistry, 2004
- Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: Its role in tumor progression and apoptosisBMC Gastroenterology, 2003
- Hepatocellular carcinoma — History, current status and perspectivesDigestive and Liver Disease, 2002
- Defective Gp130-Mediated Signal Transducer and Activator of Transcription (Stat) Signaling Results in Degenerative Joint Disease, Gastrointestinal Ulceration, and Failure of Uterine ImplantationJournal of Experimental Medicine, 2001
- Oncostatin M and Interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cellsOncogene, 2000
- Receptor recognition by gp130 cytokinesThe EMBO Journal, 2000
- Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1Oncogene, 1999
- Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptorProceedings of the National Academy of Sciences, 1997
- Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression.Proceedings of the National Academy of Sciences, 1992